Clinical Trials for Pathologic Stage IIID Cutaneous Melanoma AJCC v8

Find clinical trials for pathologic stage iiid cutaneous melanoma ajcc v8. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

NCT ID: NCT03819296

This clinical trial is examining how the gut microbiome, which is the collection of bacteria and other microorganisms in our digestive system, affects gastrointestinal (GI) problems caused by certa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

NCT ID: NCT05039801

This clinical trial is studying a new treatment called IACS-6274 for patients with advanced solid tumors, which are types of cancer that have spread beyond their original site. The trial is looking...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

NCT ID: NCT05098210

This clinical trial is exploring a new treatment option called a personalized neo-antigen peptide vaccine for patients with advanced melanoma (a type of skin cancer) or hormone receptor-positive br...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

NCT ID: NCT04462406

The PET-Stop Trial is a study looking at how doctors can use special tests called biomarkers from PET/CT scans to decide if patients with advanced melanoma can safely stop their anti-PD-1 treatment...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Durham, North Carolina, United States +513 more

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

NCT ID: NCT05269381

This clinical trial is investigating a new type of personalized vaccine designed to help the immune system recognize and attack advanced solid tumors, which are cancers that have spread beyond thei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions